Patients with FBS 126 mg/dL, HbA1c 6.5%, and/or currently using antidiabetic medication were defined as having diabetes according to the criteria of the Japan Diabetes Society [14]
Water, Dipropylene Glycol, Galactomyces Ferment Filtrate(50,029 ppm), Glycerin, Methylpropanediol, Glycereth-26, Niacinamide, Glyceryl Glucoside, Glyceryl Polymethacrylate, Erythritol, Polyglyceryl-10 Laurate, Hydroxyacetophenone, 1,2-Hexanediol, Carbomer, Caprylyl Glycol, Arginine, Hydrolyzed Jojoba Esters, Xanthan Gum, Adenosine, Glucose, Ethylhexylglycerin, Butylene Glycol, Citric Acid, Ascorbic Acid, Polyquaternium -51, Panthenol, Citrus Aurantium Bergamia (Bergamot) Fruit Oil, Diethylhexyl Sodium Sulfosuccinate, Sodium Citrate, Lavandula Angustifolia (Lavender) Oil, Glutathione(10.89 ppm), Sodium Hyaluronate, Dipotassium Glycyrrhizate, Oryza Sativa (Rice) Extract, Pyrus Malus [Apple] Fruit Extract, Saccharide Isomerate, Hydrogenated Lecithin, Pantolactone, Maltodextrin, Brassica Oleracea Italica (Broccoli) Extract, Hydrolyzed Vegetable Protein, Prunus Serrulata Flower Extract, Nelumbo Nucifera Flower Extract, Lilium Tigrin um Extract, Copper Tripeptide-1, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Sodium Hyaluronate Crosspolymer, Hydroxypropyltrimonium Hyaluronate, Potassium Hyaluronate, Hydrolyzed Sodium Hyaluronate, Pentylene Glycol, Sodium Acetylated Hyaluronate, Disodium EDTA, Limonene, Linalool
Rarely, more serious reactions such as infections or allergic responses may arise
Each dot represents a different PDX
Sustained-release glutathione Sustained-release formulations use a time-release matrix to release glutathione gradually over several hours, maintaining steadier blood levels throughout the day
As such, IV drips increase the bio-availability of the nutritional compounds, whereby the body can use them immediately
